Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
Cantor Fitzgerald
Daiichi Sankyo
Federal Trade Commission

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022427

« Back to Dashboard
NDA 022427 describes ACUVAIL, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ACUVAIL profile page.

The generic ingredient in ACUVAIL is ketorolac tromethamine. There are eighteen drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine profile page.

Summary for NDA: 022427

Therapeutic Class:Analgesics
Anti-inflammatory Agents
Ophthalmic Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 022427

Suppliers and Packaging for NDA: 022427

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ketorolac tromethamine
SOLUTION/DROPS;OPHTHALMIC 022427 NDA Allergan, Inc. 0023-3507 0023-3507-05 5 VIAL, SINGLE-USE in 1 CARTON (0023-3507-05) > .4 mL in 1 VIAL, SINGLE-USE
ketorolac tromethamine
SOLUTION/DROPS;OPHTHALMIC 022427 NDA Allergan, Inc. 0023-3507 0023-3507-30 30 VIAL, SINGLE-USE in 1 CARTON (0023-3507-30) > .4 mL in 1 VIAL, SINGLE-USE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.45%
Approval Date:Jul 22, 2009TE:ATRLD:Yes
Patent:7,842,714Patent Expiration:Aug 15, 2029Product Flag?YSubstance Flag?YDelist Request?
Patent:8,512,717Patent Expiration:Mar 7, 2028Product Flag?YSubstance Flag?Delist Request?
Patent:8,992,952Patent Expiration:Aug 5, 2024Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
Daiichi Sankyo
US Department of Justice
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus